Filing Details
- Accession Number:
- 0001127602-14-005709
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-02-11 20:41:16
- Reporting Period:
- 2014-02-07
- Filing Date:
- 2014-02-11
- Accepted Time:
- 2014-02-11 20:41:16
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 850693 | Allergan Inc | AGN | Pharmaceutical Preparations (2834) | 951622442 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1501399 | D Scott Sherman | 2525 Dupont Drive Irvine CA 92612 | Executive Vice President, Hr | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-02-07 | 4,500 | $73.04 | 12,825 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-02-07 | 4,500 | $118.55 | 8,325 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2014-02-10 | 5,000 | $75.58 | 13,325 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-02-10 | 5,000 | $120.00 | 8,325 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2014-02-07 | 4,500 | $0.00 | 4,500 | $73.04 |
| Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2014-02-10 | 5,000 | $0.00 | 5,000 | $75.58 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 7,500 | 2020-11-03 | No | 4 | M | Direct | |
| 35,000 | 2021-02-17 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 1,258 | Indirect | By 401(k) |
Footnotes
- The price reported in column 4 is the weighted average price. These shares were sold in transactions at prices ranging from $118.540 to $118.560. The reporting person undertakes to provide Allergan, Inc. any security holder of Allergan, Inc., or the staff of the Securities and Exchange Commission, upon request, the full information regarding the number of shares sold at each price within the range set forth in this footnote.
- Shares allocated to reporting person's SIP account as of reporting date.
- The option becomes exercisable in four equal annual installments beginning November 3, 2011.
- The option becomes exercisable in four equal annual installments beginning February 17, 2012.
Billionaire Hedge Funds
